SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001596783-22-000025
Filing Date
2022-02-01
Accepted
2022-02-01 07:05:24
Documents
16
Period of Report
2022-01-27
Items
Item 2.02: Results of Operations and Financial Condition
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K ctlt-20220127.htm   iXBRL 8-K 41797
2 EX-3.2 catalentex32-bylaws27jan20.htm EX-3.2 217759
3 EX-99.1 earningsreleaseex991-fy22x.htm EX-99.1 531460
7 image1.jpg GRAPHIC 45267
8 image_0a.jpg GRAPHIC 38171
  Complete submission text file 0001596783-22-000025.txt   1124920

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT ctlt-20220127.xsd EX-101.SCH 2219
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT ctlt-20220127_lab.xml EX-101.LAB 25832
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT ctlt-20220127_pre.xml EX-101.PRE 13790
10 EXTRACTED XBRL INSTANCE DOCUMENT ctlt-20220127_htm.xml XML 11250
Mailing Address 14 SCHOOLHOUSE ROAD SOMERSET NJ 08873
Business Address 14 SCHOOLHOUSE ROAD SOMERSET NJ 08873 (732) 537-6200
Catalent, Inc. (Filer) CIK: 0001596783 (see all company filings)

IRS No.: 208737688 | State of Incorp.: DE | Fiscal Year End: 0630
Type: 8-K | Act: 34 | File No.: 001-36587 | Film No.: 22576868
SIC: 2834 Pharmaceutical Preparations